📉 Stocks of Vaccine Makers Slide Amid RFK Jr.'s HHS Nomination

President-elect Donald Trump’s decision to nominate Robert F. Kennedy Jr., a known vaccine skeptic, as the head of the U.S. Department of Health and Human Services triggered declines in vaccine maker stocks. Major U.S. firms like Pfizer, Eli Lilly, and Novavax, along with international companies such as AstraZeneca and BioNTech, faced drops in share prices. Concerns stem from Kennedy's history of promoting anti-vaccine rhetoric and advocating against corporate influence in health agencies, signaling potential regulatory disruptions ahead.